Browse the evidence

Fat-free mass (FFM) increased by 2.3% in the whey protein group, 3.6% in the chia flour group, and 3.0% in the placebo group.

The study provides specific data on how much FFM increased in each group, which can inform future research and practice.

UPFs increase the risk of chronic diseases and death.

Public health initiatives should address the risks associated with UPF consumption.

A 3-month regimen of nutrition counseling and high-intensity resistance training resulted in a 6.6% reduction in body fat and a 1.4% increase in muscle mass.

Practitioners can implement similar exercise and nutrition regimens to promote fat loss and muscle gain in breast cancer patients.

All groups demonstrated improvements in the measured outcomes.

Resistance training is effective for improving strength and muscle outcomes in females.

Kin teams lost more weight after the intervention in the gamification and gamification with PCP sharing arms.

Practitioners may consider the social dynamics of participant pairs when implementing weight loss interventions.

Married teams lost the most weight across all 3 arms and kept it off following the intervention.

Understanding the characteristics of successful participants can inform future intervention designs.

A 20-min walk post-breakfast reduces postprandial hyperglycaemia in Early (0700 h) and Delayed (1200 h) conditions.

Encouraging a short walk after breakfast may help manage blood sugar levels in patients with type 2 diabetes.

A 12-week partial meal replacement (PMR) diet is effective for weight loss in overweight or obese patients after ischemic stroke, with 52.9% of participants achieving ≥5% weight loss compared to 11.9% in the standard care group.

Healthcare providers can consider PMR diets as a viable option for weight management in stroke patients.

Behavioral treatment for obesity includes components such as self-monitoring, functional analyses, stimulus control, cognitive restructuring, problem-solving, and relapse prevention.

Practitioners should incorporate these components into obesity treatment programs.

Weight loss requires the induction of a negative energy balance.

Weight loss strategies should focus on creating a negative energy balance.

Patient-delivered lifestyle intervention yielded significantly less weight regain than standard-of-care (SOC) at month 18 (0.77 kg vs 2.37 kg; P = .002).

Patient-delivered interventions may be a viable alternative for weight loss maintenance.

Patient-delivered intervention showed parallel improvements in diastolic blood pressure, heart rate, physical activity, and sedentary behavior compared to SOC.

Improving cardiovascular metrics can enhance overall health in weight maintenance programs.

During peak week, frequency, volume, and intensity of resistance training decreased while repetition ranges of compound exercises increased.

Competitors should focus on adjusting their training load to reduce stress while increasing repetitions for compound movements.

Each 100 MET-min/wk increase in accelerometry-measured moderate-to-vigorous physical activity (MVPA) from baseline to 4 years is associated with decreased risk of cardiovascular disease (CVD) outcomes.

Encouraging long-term engagement in MVPA can help reduce CVD risk in this population.

Increased accelerometry-measured MVPA from baseline to year 4 is associated with decreased risk of CVD outcomes.

Long-term engagement in MVPA is crucial for reducing CVD risk in this demographic.

Among individuals with central adiposity, replacing SSB with either ASB or USB had a favorable effect on body weight.

Practitioners may consider recommending ASB or USB for weight management in individuals with central adiposity.

Semaglutide led to a mean relative weight loss of 13.3 ± 11.3% after 12 months in adults with type 1 diabetes.

Practitioners can consider semaglutide as an effective option for weight management in overweight/obese patients with type 1 diabetes.

Initiation of semaglutide was significantly associated with a -3.8% reduction in weight at 13 to 24 months.

Semaglutide may be an effective option for weight management in adults.

The appropriate use of NB-ER should consider the specific characteristics and adiposity-related complications of an individual.

Practitioners should assess individual patient characteristics when prescribing NB-ER.

Tirzepatide has been approved by the FDA for treating T2D and managing chronic weight in overweight or obese patients.

Healthcare providers can confidently prescribe tirzepatide for eligible patients based on FDA approval.

Protein sources and physical activity were positively associated with lean mass in males and/or females.

Encouraging high-quality protein sources and physical activity is beneficial for maintaining lean mass in both sexes.

Current guidelines recommend a healthier lifestyle for all CV risk categories.

Healthcare providers should promote lifestyle changes as a preventive measure for cardiovascular disease.

Lifestyle interventions can reduce the incidence of myocardial infarction and the risk of developing type 2 diabetes.

Encouraging lifestyle changes can significantly lower the risk of serious health issues like heart attacks and diabetes.

The Mediterranean diet is advised for cardiovascular prevention in patients with familial hypercholesterolemia (FH).

Practitioners should consider recommending the Mediterranean diet to patients with FH.